PULMATRIX, INC. Other Non-Current Assets
PULMATRIX, INC. (PULM) had Other Non-Current Assets of $13.00 thousand as of 2024-12-31, per its S-4/A filed 2026-09-17.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-09-17
- 2024-12-31: Other Assets, Noncurrent $13.00K.
- 2024-09-30: Other Assets, Noncurrent $54.00K.
- 2024-06-30: Other Assets, Noncurrent $93.00K.
- 2024-03-31: Other Assets, Noncurrent $135.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2024-12-31 | $13.00K S-4/A · filed 2026-09-17 |
| 2024-09-30 | $54.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $93.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $135.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $176.00K 10-K · filed 2025-03-21 |
| 2023-09-30 | $217.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.98M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $899.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $389.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $428.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $368.00K 10-Q · filed 2022-08-10 |
| 2015-09-30 | $18.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $22.00K 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |